Pharming Intellectual Property B.V.
12Patents
5Active
12Granted
40Portfolio score
Filing activity: Jun 7, 1995 → Feb 25, 2013 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8071532B2 | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury | Human Necessities | 26 | Active |
| US8415288B2 | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury | Human Necessities | 23 | Active |
| US7067713B2 | C1 Inhibitor produced in the milk of transgenic non-human mammals | Human Necessities | 15 | Expired |
| US7544853B2 | C1 inhibitor with short half-life transient treatment | Human Necessities | 11 | Expired |
| USRE43691E1 | C1 inhibitor with short half-life transient treatment | General | 8 | Expired |
| US7045677B2 | Fusion proteins incorporating lysozyme | Chemistry; Metallurgy | 8 | Expired |
| US6713662B1 | Production of collagen in the milk of transgenic mammals | Chemistry; Metallurgy | 6 | Expired |
| US7211650B2 | Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography | Human Necessities | 5 | Expired |
| USRE42704E1 | Production of fibrinogen in transgenic animals | General | 0 | Expired |
| US9408366B2 | Milking device | Human Necessities | 0 | Active |
| US9211318B2 | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury | Human Necessities | 0 | Active |
| US9546381B2 | Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.